165 related articles for article (PubMed ID: 22093033)
1. Hepatitis C virus and the immunological response to hepatitis B virus vaccine in dialysis patients: meta-analysis of clinical studies.
Fabrizi F; Dixit V; Martin P; Messa P
J Viral Hepat; 2011 Dec; 18(12):871-6. PubMed ID: 22093033
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis: the impact of diabetes mellitus on the immunological response to hepatitis B virus vaccine in dialysis patients.
Fabrizi F; Dixit V; Martin P; Messa P
Aliment Pharmacol Ther; 2011 Apr; 33(7):815-21. PubMed ID: 21281319
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis: levamisole improves the immune response to hepatitis B vaccine in dialysis patients.
Fabrizi F; Dixit V; Messa P; Martin P
Aliment Pharmacol Ther; 2010 Sep; 32(6):756-62. PubMed ID: 20662784
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus vaccine in chronic kidney disease: improved immunogenicity by adjuvants? A meta-analysis of randomized trials.
Fabrizi F; Dixit V; Messa P; Martin P
Vaccine; 2012 Mar; 30(13):2295-300. PubMed ID: 22285268
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin use and immunogenicity of hepatitis B virus vaccine in chronic kidney disease patients: a meta-analysis.
Fabrizi F; Dixit V; Martin P; Messa P
Kidney Blood Press Res; 2012; 35(6):504-10. PubMed ID: 22813903
[TBL] [Abstract][Full Text] [Related]
6. Intradermal vs intramuscular vaccine against hepatitis B infection in dialysis patients: a meta-analysis of randomized trials.
Fabrizi F; Dixit V; Messa P; Martin P
J Viral Hepat; 2011 Oct; 18(10):730-7. PubMed ID: 20819147
[TBL] [Abstract][Full Text] [Related]
7. Factors affecting responsiveness to hepatitis B immunization in dialysis patients.
Asan A; Demirhan H; Sorkun HÇ; Özkan S; Aydın M; Akın D; Tatar B; Çatak B; Şener A; Köse Ş
Int Urol Nephrol; 2017 Oct; 49(10):1845-1850. PubMed ID: 28620716
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis: the effect of age on immunological response to hepatitis B vaccine in end-stage renal disease.
Fabrizi F; Martin P; Dixit V; Bunnapradist S; Dulai G
Aliment Pharmacol Ther; 2004 Nov; 20(10):1053-62. PubMed ID: 15569107
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis: the adjuvant role of granulocyte macrophage-colony stimulating factor on immunological response to hepatitis B virus vaccine in end-stage renal disease.
Fabrizi F; Ganeshan SV; Dixit V; Martin P
Aliment Pharmacol Ther; 2006 Sep; 24(5):789-96. PubMed ID: 16918882
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis: the dialysis mode and immunological response to hepatitis B virus vaccine in dialysis population.
Fabrizi F; Dixit V; Bunnapradist S; Martin P
Aliment Pharmacol Ther; 2006 Apr; 23(8):1105-12. PubMed ID: 16611270
[TBL] [Abstract][Full Text] [Related]
11. Effects of oral levamisole as an adjuvant to hepatitis B vaccine in adults with end-stage renal disease: a meta-analysis of controlled clinical trials.
Alavian SM; Tabatabaei SV
Clin Ther; 2010 Jan; 32(1):1-10. PubMed ID: 20171406
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
[TBL] [Abstract][Full Text] [Related]
13. [Prevalence of response to anti-HBV infection in patients on maintenance hemodialysis infected with hepatitis C virus (HCV)].
Muszytowski M; Manitius J; Ruszkiewicz-Fołda M
Przegl Lek; 1996; 53(5):417-9. PubMed ID: 8754404
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis: the adjuvant role of thymopentin on immunological response to hepatitis B virus vaccine in end-stage renal disease.
Fabrizi F; Dixit V; Martin P
Aliment Pharmacol Ther; 2006 Jun; 23(11):1559-66. PubMed ID: 16696803
[TBL] [Abstract][Full Text] [Related]
15. Does infection by the hepatitis C virus decrease the response of immunization against the hepatitis B virus in individuals undergoing dialysis?
Ferreira TMB; Guimarães TGS; Fontenele AMM; Salgado N; Ferreira ASP; Costa APM
J Bras Nefrol; 2017; 39(2):141-145. PubMed ID: 28489180
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B vaccine in hemodialysis patients with hepatitis C viral infection.
Cheng CH; Huang CC; Leu ML; Chiang CY; Wu MS; Lai PC
Vaccine; 1997; 15(12-13):1353-7. PubMed ID: 9302744
[TBL] [Abstract][Full Text] [Related]
17. The effect of diabetes mellitus on immunological response to hepatitis B virus vaccine in individuals with chronic kidney disease: A meta-analysis of current literature.
Alavian SM; Tabatabaei SV
Vaccine; 2010 May; 28(22):3773-7. PubMed ID: 20371390
[TBL] [Abstract][Full Text] [Related]
18. Response to hepatitis B virus vaccination in haemodialysis patients with and without hepatitis C infection.
Sorkhi H; Roushan MR; Al Hashemi GH; Dooki MR; Bai S
East Mediterr Health J; 2008; 14(4):798-803. PubMed ID: 19166162
[TBL] [Abstract][Full Text] [Related]
19. Antibody level after hepatitis B vaccination in hemodialysis patients: influence of hepatitis C virus infection.
Navarro JF; Teruel JL; Mateos ML; Marcen R; Ortuno J
Am J Nephrol; 1996; 16(2):95-7. PubMed ID: 8919223
[TBL] [Abstract][Full Text] [Related]
20. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients.
Kara IH; Yilmaz ME; Suner A; Kadiroglu AK; Isikoglu B
Vaccine; 2004 Sep; 22(29-30):3963-7. PubMed ID: 15364445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]